arrow
N

Nathan P. Wiederhold

University of Texas Health Science Center at San Antonio
H指数:71
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic Challenges of Non-Sporulating Fungal Isolates Recovered from Traumatic Wounds Following Motor Vehicle Collisions: Subramaniula asteroides and Aspergillus quadrilineatus in the United Arab Emirates

从交通事故创伤伤口中分离的非产孢真菌鉴定挑战:阿联酋的Subramaniula asteroides和Aspergillus quadrilineatus

2026-09-220
OA
Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis

巴西副球孢子菌抗真菌药物敏感性检测的标准化研究

2026-08-190
OAAI
Prevalence of cyp51A variants in a US collection of Aspergillus fumigatus clinical isolates and comparative analysis of their contribution to triazole antifungal resistance

美国曲霉菌临床分离株中CYP51A变体的流行率及其对三唑类抗真菌药物耐药性的贡献比较分析

2026-04-210
OA
Closing the gap on antifungal resistance

缩小抗真菌耐药性的差距

2026-04-150
PRE
Global Emergence of Antifungal-Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytes ITS Genotype VIII): A Genomic Investigation Involving 14 Countries

由Trichophyton indotineae(原T. mentagrophytes ITS基因型VIII)引起的抗真菌耐药性皮肤癣菌病的全球出现:一项涉及14个国家的基因组学研究

Mycoses
IF3.1
2025-08-140
PRE
Fungal Meningitis in US Patients Who Received Epidural Anesthesia in Matamoros, Mexico

在美国患者中,接受在Matamoros(墨西哥)硬膜外麻醉后的真菌性脑膜炎

2025-08-010
PRE
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People

2025年美国传染病学会关于组织胞浆菌病的临床实践指南更新:成人和儿童轻度或中度急性肺组织胞浆菌病的治疗,以及孕妇的治疗

2025-07-010
PRE
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) in Adults, Children, and Pregnant People

2025年美国传染病学会关于组织胞浆菌病的临床实践指南更新:成人和儿童及孕妇无症状组织胞浆菌肺部结节(组织胞浆菌瘤)的治疗

2025-07-010
OA
Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications

为暗色丝孢霉病的主要病原体Fonsecaea pedrosoi建立流行病学临界值,并针对八种抗真菌药物。

2025-05-140
OA